|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Less: Allowance for credit losses | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $6 and $41, respectively | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Cash equivalents and marketable securities held in Trust Account | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Bifurcated embedded derivative asset | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Simple agreement for future equity | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Convertible notes | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| CP BF | ||||||||||||||||||||
| Yorkville | ||||||||||||||||||||
| Total convertible notes | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Excise Tax Payable | ||||||||||||||||||||
| Franchise tax payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Bifurcated embedded derivative liabilities | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total bifurcated embedded derivative liabilities | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Deferred underwriting fees | ||||||||||||||||||||
| Deferred fee | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Due to related party | ||||||||||||||||||||
| GEM commitment fee liability | ||||||||||||||||||||
| Convertible notes, carried at fair value | ||||||||||||||||||||
| Notes payable, carried at fair value | ||||||||||||||||||||
| Private placement warrant liability | ||||||||||||||||||||
| Financial instruments - related party | ||||||||||||||||||||
| Earnout liability | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Operating lease liabilities, current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred underwriting fees payable | ||||||||||||||||||||
| Derivative warrant liabilities | ||||||||||||||||||||
| Deferred revenue, non-current | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Operating lease liabilities, non-current | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Class A common stock subject to possible redemption, $0.0001 par value; 3,329,638 and 5,076,777 shares at $10.65 and $10.23 per share at September 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Common stock, $0.0001 par value, 275,000,000 (250,000,000 Class A and 25,000,000 Class B) shares authorized and 2,690,579 (2,656,723 Class A and 33,856 Class B) and 527,317 (515,761 Class A and 11,556 Class B) shares issued and outstanding at June 30, 2026 and 2025, respectively | ||||||||||||||||||||
| Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 5,750,000 shares issued and outstanding at September 30, 2023 and December 31, 2022 | ||||||||||||||||||||
| Preferred stock, $0.0001 par value, 75,000,000 shares authorized, 1 and 1 shares issued and outstanding at June 30, 2026 and 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
